Abcellera Biologics Inc
ABCL
$11.80-6.94%
End of day · as of Oct 17, 2026, 2:15 AM ET
Mkt cap
$1.12B
EV/Sales
13.1
P/E ratio
N/A
FY2025 Revenue
$75.13M
EPS (TTM)
$-0.54
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-194.88%
Beta
0.36
Div yield
N/A
Sector
Healthcare
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Latest reported ABCL revenue for 2025-12-31 was $75.1M. Net income was -$146.4M. Revenue was up 160.6% from 2024-12-31 to 2025-12-31. ABCL currently screens at market cap $1.12B.
Use this ABCL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ABCL income, balance, and cash tables.
Abcellera Biologics Inc (ABCL) is a biotechnology company in the Healthcare sector.
Latest cached Abcellera Biologics Inc (ABCL) revenue for Dec 31, 2025 was $75.1M. Net income was -$146.4M. Statements: https://lician.com/financials/abcl
Abcellera Biologics Inc (ABCL) market capitalization is $1.12B on the latest cached snapshot.
Abcellera Biologics Inc (ABCL) cached previous close $12.68; day range $11.80 – $12.68; volume 4,097,189. Session quote: https://lician.com/quote/abcl
Abcellera Biologics Inc (ABCL) latest cached earnings event is "ABCL earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ABCL filing is 8-K · Aug 13, 2026. Filings: https://lician.com/sec/abcl